Fast Track Initiative Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 8
- Investments
- 42
- Portfolio
- 19
- Exits
- 8
Fast Track Initiative General Information
Description
Fast Track Initiative (FTI) is a healthcare-focused venture capital firm that has offices in Tokyo and Boston. The firm invests primarily in biotech, with a secondary focus in healthcare services and digital health. For those fields, the firm is interested in first-in-class technology approaches and invest in early companies with great science, from seed to series B. With their expansion to the US, the firm is now open to investing globally. The firm has generally led investments but is willing to be part of a syndicate as well.
Contact Information
Website
www.fti-jp.com/index_e.html
Year Founded
2004
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Unizo Hongo 4 chome Building
- 2F, 4-1-4 Hongo, Bunkyo-ku
- Tokyo, 113-0033
- Japan
+81 00-0000-0000
Fast Track Initiative Investments (42)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| A10 Lab | 28-Feb-2022 | Later Stage VC | 00.000 | Information Services (B2C) | Generating Revenue | 00000000 00000 00.0 |
| 0000 000000 | 25-Aug-2021 | 00000 00000 | Clinics/Outpatient Services | Generating Revenue | ||
| 0000000 0000000000 | 09-Jul-2021 | 00000 00000 | 00.000 | Drug Delivery | Generating Revenue | 000000 000000 00.0 |
| 000000 00000000000 | 11-Jun-2021 | 00000 00000 | 00.000 | Therapeutic Devices | Generating Revenue | 000000 000000 00.0 |
| 0000000 0000000000 | 16-Mar-2021 | 0000 00000 | 00000 | Biotechnology | Generating Revenue | |
| 000 000000000 | 04-Dec-2020 | 00000 00000 | 00.000 | Drug Discovery | Generating Revenue | 00000000 00000 00.0 |
| 0000 0000000 | 01-Sep-2020 | 00000 00000 | 00.00 | Drug Discovery | Generating Revenue | 000000 000000 00.0 |
| 0000000 | 13-May-2020 | 00000 00000 | 000.00 | Drug Discovery | Pre-Clinical Trials | 00000000 00000 00.0 |
| Mental Health Technologies | 27-Apr-2020 | Later Stage VC | 00.000 | Clinics/Outpatient Services | Generating Revenue | |
| Cytlimic | 09-Aug-2019 | Early Stage VC | 000.00 | Drug Discovery | Generating Revenue | 000000 000000 00.0 |
Fast Track Initiative Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| AccuRna | 30-Sep-2020 | Merger/Acquisition | 000.00 |
| 0000000 (000000000 | 03-Aug-2020 | 000 | 000.00 |
| 000000 | 01-Sep-2019 | 000 00 00000000 | |
| 0000000000 0000000 | 22-Oct-2015 | 000 | 000.00 |
| 000000 | 01-Oct-2013 | 000000000000000000 | 00.00 |
| Japan Medical Information Research Institute | 31-Aug-2012 | Merger/Acquisition | 00.00 |
| CellSeed | 16-Mar-2010 | IPO | 0000 |
Fast Track Initiative Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialFast Track Initiative Team (11)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Tomohiro Anzai Ph.D | Chief Operating Officer & Managing Partner | 00 | 0 | 0 | Tokyo, Japan |
| Makoto Takeuchi | Senior Venture Expert | Tokyo, Japan | |||
| Taku Nakahara Ph.D | Venture Expert | 0 | 0 | Tokyo, Japan | |
| Hajime Okuyama Ph.D | Manager | 0 | Tokyo, Japan | ||
| Hiroko Kimura Ph.D | Manager | 0 | 0 | 0 | Tokyo, Japan |
Fast Track Initiative Co-Investors (46)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| SMBC Venture Capital | 7 | 0 |
|
|
|
| UTokyo Innovation Platform | 0 | 0 | 0 |
|
|
| SBI Investment | 0 | 0 |
|
|
|
| Mizuho Venture Capital | 0 | 0 |
|
|
|
| Nippon Venture Capital | 0 | 0 |
|
|